Brief: Orexo Completes First Preclinical Study Of Oral Semaglutide Tablet
14/10/2026 07:03
BRIEF-Orexo Completes First Preclinical Study Of Oral Semaglutide Tablet Oct 14 (Reuters) - Orexo AB ORX.ST:
COMPLETES FIRST PRECLINICAL STUDY OF ORAL SEMAGLUTIDE TABLET USING AMORPHOX TECHNOLOGY
PRIOR TO ANY OPTIMIZATION LEAD AMORPHOX ORAL SEMAGLUTIDE TABLET DEMONSTRATED BIOAVAILABILITY COMPARABLE TO THAT OF REFERENCE TABLET
RESULTS PROVIDE AN ENCOURAGING STARTING POINT FOR FURTHER FORMULATION OPTIMIZATION
Source text: ID:nMFN15JdjF
Further company coverage: ORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))